What do Aib, D-2-Nal and NH2 mean in the Ipamorelin sequence?
The Ipamorelin sequence contains five amino-acid residues, but more than five hyphen-separated parts. Here we separate the residues themselves from information about their structure, so the line can be read without losing important details.
Five residues, from the N- to the C-terminus
Raun and colleagues describe Ipamorelin as a pentapeptide in their 1998 paper. The reported sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2. Counted as amino-acid residues, the order is Aib, His, D-2-Nal, D-Phe and Lys.
Under the IUPAC writing convention, a peptide chain is read from the N-terminus to the C-terminus, left to right. Here, Aib is therefore at the N-terminus and Lys at the C-terminus. The NH2 ending describes the terminal group, not another amino acid.
Aib is not a misspelling of Ala
Aib stands for alpha-aminoisobutyric acid, also called 2-methylalanine. The PubChem structure shows two methyl groups attached to the alpha carbon. Describing Aib as an amino acid without a side chain is therefore misleading. Ala instead denotes alanine; the two abbreviations should not be treated as interchangeable when reproducing a sequence.
D and the number 2 mean different things
D-2-Nal is the D form of 3-(2-naphthyl)alanine. The number 2 specifies the naphthyl attachment position in the ring system, not the residue's position in the peptide chain. This is the third residue in Ipamorelin. D-Phe is D-phenylalanine and occupies position four. FDA substance record Y9M3S784Z6 spells out these structural components in a longer name.
The D prefix specifies stereochemical configuration. For chiral amino acids, IUPAC symbols normally denote the L form unless otherwise indicated. Here, His and Lys stand for L-histidine and L-lysine respectively; the D labels must therefore be retained.
NH2 indicates a terminal amide
Lys-NH2 means that the C-terminal carboxyl group is an amide, –CONH2, rather than a free carboxyl group. It describes the end of the chain, not a sixth residue. IUPAC's amide examples explain the notation; accordingly, the name in the FDA record ends in L-lysinamide.
A simple check when comparing two records
Start by copying the five residues in order. Then check prefixes, numbers and the terminal group separately. Simply counting hyphens gives the wrong total because that same character also occurs within D-2-Nal and D-Phe.
Record which source and version you are comparing against. If two documents differ, mark the exact difference instead of correcting the line based on the product name. Reading the sequence helps you frame a precise question about the documentation. It does not verify the identity or quality of the store's materials.
Related research standards
Related articles
Research use only. Invus Labs products are laboratory reference standards for in-vitro research — not for human or veterinary use.